Sleep Study Cutoffs May Guide Discharge

Preoperative sleep study values may distinguish lower-risk children within a population for whom overnight admission is currently routine.

By
Andrea Surnit
June 5, 2026
6 min

MDSpire News

Overview

A retrospective study found that most pediatric patients with obesity and severe obstructive sleep apnea classified as high risk for tonsillectomy complications did not experience severe perioperative events.

Background

Identifying patients at risk for complications following tonsillectomy is crucial for optimizing perioperative care. Current guidelines recommend overnight admission for high-risk patients, including those with severe obstructive sleep apnea and obesity. This study evaluates the effectiveness of preoperative polysomnography cutoffs in stratifying risk among pediatric patients.

Data Highlights

Outcome	Number of Patients	Percentage
Severe perioperative events	36	12%
ICU admissions	20	-
Advanced respiratory support	17	-
Hospital stays > 48 hours	32	-

Key Findings

88% of high-risk patients did not experience severe perioperative events.
36 patients (12%) experienced a severe perioperative event.
Oxygen saturation nadir was the strongest predictor of severe perioperative events.
Among patients with AHI below 25 and oxygen saturation nadir above 85%, only 1 out of 87 experienced a respiratory-focused severe event.
The model-derived low-risk group had a predicted severe-event probability of 5% or lower.
Routine admission of all high-risk patients carries an estimated annual cost burden of about $331 million.

Clinical Implications

The findings suggest that preoperative polysomnography cutoffs may aid in identifying lower-risk pediatric patients for tonsillectomy, potentially reducing unnecessary overnight admissions. This could improve healthcare utilization and surgical capacity.

Conclusion

The study indicates that preoperative polysomnography may help stratify risk in pediatric patients with obesity and severe obstructive sleep apnea undergoing tonsillectomy, warranting further investigation into its clinical application.